biotech / news / / Devdiscourse
Sun Pharmaceutical Industries Ltd has announced a landmark acquisition of Organon & Co, a US-based company, for a whopping USD 11.75 billion.
Sun Pharmaceutical will acquire US-based Organon & Co for USD 11.75 billion.
KEY POINTS
- This is the largest-ever overseas acquisition by an Indian pharmaceutical company.
- The deal is India's second-largest outbound transaction after Tata Steel's Corus acquisition.
- Sun Pharma's acquisition of Organon will strengthen India's position in the global pharmaceutical market.
COMPANIES
Summarized by Newsio from Devdiscourse. How we summarize →